| Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer KL Bryant, CA Stalnecker, D Zeitouni, JE Klomp, S Peng, AP Tikunov, ... Nature medicine 25 (4), 628-640, 2019 | 600 | 2019 |
| Intermittent glucocorticoid treatment enhances skeletal muscle performance through sexually dimorphic mechanisms IM Salamone, M Quattrocelli, DY Barefield, PG Page, I Tahtah, ... The Journal of clinical investigation 132 (6), 2022 | 27 | 2022 |
| Author Correction: Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer KL Bryant, CA Stalnecker, D Zeitouni, JE Klomp, S Peng, AP Tikunov, ... Nature medicine 26 (6), 982-982, 2020 | 6 | 2020 |
| Susceptibility to innate immune activation in genetically mediated myocarditis DF Selgrade, DE Fullenkamp, IA Chychula, B Li, L Dellefave-Castillo, ... The Journal of Clinical Investigation 134 (13), 2024 | 1 | 2024 |
| Inhibition of ERK MAPK signaling increases pancreatic cancer dependency on autophagy K Bryant, S Peng, A Tikunov, M Pierobon, V Gunda, G Tomar, P Singh, ... Cancer Research 78 (13_Supplement), 5492-5492, 2018 | 1 | 2018 |
| Reduction of Filamin C Results in Altered Proteostasis, Cardiomyopathy, and Arrhythmias JC Ohiri, L Dellefave‐Castillo, G Tomar, L Wilsbacher, L Choudhury, ... Journal of the American Heart Association 13 (10), e030467, 2024 | | 2024 |
